Prenetics Global Limited WarrantPRENW
About: Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
Employees: 320
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
10% more capital invested
Capital invested by funds: $31.6K [Q4 2024] → $34.7K (+$3.05K) [Q1 2025]
2.79% less ownership
Funds ownership: 29.79% [Q4 2024] → 26.99% (-2.79%) [Q1 2025]
6% less funds holding
Funds holding: 16 [Q4 2024] → 15 (-1) [Q1 2025]
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Research analyst outlook
We haven’t received any recent analyst ratings for PRENW.
Financial journalist opinion
We haven’t received any recent news articles for PRENW.